COPD CBD Gummy Bears: What Real Experience and Limited Evidence Actually Show
COPD CBD gummy bears are gaining attention for symptom management, especially breathlessness and sleep issues. While patient reports suggest benefits, clinical evidence remains limited. This article reviews the current understanding of copd cbd gummy…
Kana CBD Gummies for COPD: What Real-World Experience and Evidence Actually Show
CBD gummies for COPD are gaining attention due to their potential anti-inflammatory properties. Current evidence remains limited, emphasizing the need for more research. This article reviews real-world experience and clinical insights on CBD gummies for…
Managing Respiratory Health During Early Wildfire Smoke Season
Wildfire smoke respiratory health is a critical concern for patients using cannabis therapeutically. Exposure to wildfire smoke exacerbates respiratory conditions like asthma and COPD. Cannabis treatment planning must consider safer delivery methods…
In the Mix: 13 More Articles — April 06, 2026
In the Mix — Last 24 HoursApril 06, 2026. 13 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score. #25Burden of RSV-Associated Hospitalizations Highest in Older Adults With CHF, COPDThis article…
Older Adults with COPD More Likely to Receive Potentially Risky Cannabinoid Prescriptions, Study Finds
Synthetic cannabinoid prescribing COPD older adults is more common than in those without COPD, according to a large population study. The study found higher frequency and doses of off-label synthetic cannabinoids among older adults with COPD. These…
Older Adults with COPD Were Prescribed Synthetic Cannabinoids More Often—and at Higher Doses—Than Those Without the Disease
Synthetic oral cannabinoid prescribing is significantly more common among older adults with COPD compared to those without the disease. These patients also receive higher doses and longer treatment durations. Understanding these prescribing patterns is…
Reducing Severe Breathlessness with Dronabinol in Severe COPD Patients
The dronabinol COPD breathlessness trial investigates synthetic THC's potential to alleviate severe dyspnea in advanced COPD patients. This randomized, double-blinded crossover study evaluates breathing discomfort and lung function. Results will inform…